Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. [electronic resource]
Producer: 20180118Description: 835-842 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Antiphospholipid Syndrome -- blood
- Aspirin -- therapeutic use
- Female
- Fibrinolytic Agents -- therapeutic use
- Heparin, Low-Molecular-Weight -- therapeutic use
- Humans
- Membrane Proteins -- blood
- Placenta -- metabolism
- Pregnancy
- Pregnancy Complications -- blood
- Pregnancy Outcome
- Pregnancy Trimester, First -- blood
- Vascular Endothelial Growth Factor Receptor-1 -- blood
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.